Table III.
Correlation between NEK2 expression and clinicopathological characteristics of HCC patients.
| NEK2 | ||||
|---|---|---|---|---|
| Category | n | Low expression | High expression | p-value |
| Sex | ||||
| Female | 29 | 20 | 9 | 0.543 |
| Male | 230 | 141 | 89 | |
| Age | ||||
| <60 | 198 | 127 | 71 | 0.291 |
| ≥60 | 61 | 34 | 27 | |
| HBsAg | ||||
| Negative | 31 | 18 | 13 | 0.695 |
| Positive | 228 | 139 | 84 | |
| AFP | ||||
| ≥200 | 148 | 94 | 54 | 0.608 |
| <200 | 111 | 67 | 44 | |
| Size | ||||
| ≥5 | 188 | 109 | 79 | 0.031 |
| <5 | 71 | 52 | 19 | |
| Tumor nos. | ||||
| >1 | 84 | 49 | 35 | 0.413 |
| 1 | 175 | 112 | 63 | |
| Liver cirrhosis | ||||
| Present | 206 | 125 | 81 | 0.347 |
| Absent | 53 | 36 | 17 | |
| Capsulation | ||||
| Capsulated | 96 | 55 | 41 | 0.019 |
| Non-capsulated | 163 | 106 | 57 | |
| Vascular invasion | ||||
| Absent | 208 | 132 | 76 | 0.422 |
| Present | 51 | 29 | 22 | |
| Edmondson grade | ||||
| I–II | 201 | 126 | 75 | 0.760 |
| III–IV | 58 | 35 | 23 | |
p<0.05 is highlighted as bold text.